In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Liquaemin sodium preservative free Drug Master File in Korea (Liquaemin sodium preservative free KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Liquaemin sodium preservative free. The MFDS reviews the Liquaemin sodium preservative free KDMF as part of the drug registration process and uses the information provided in the Liquaemin sodium preservative free KDMF to evaluate the safety and efficacy of the drug.
After submitting a Liquaemin sodium preservative free KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Liquaemin sodium preservative free API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Liquaemin sodium preservative free suppliers with KDMF on PharmaCompass.